phenformin has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bass, AJ; Beeson, CC; Beeson, GC; Diehl, JA; Ogretmen, B; Oleinik, N; Parnham, S; Qie, S; Rustgi, AK; Wong, KK; Yoshida, A | 1 |
| Balitskiĭ, KP; Paliukh, AR; Shmal'ko, IuP; Tarutinov, VI; Vinnitskiĭ, VB | 1 |
2 other study(ies) available for phenformin and Esophageal Neoplasms
| Article | Year |
|---|---|
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; F-Box Proteins; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Humans; Hypoglycemic Agents; Male; Mechanistic Target of Rapamycin Complex 1; Metformin; Mice; Molecular Targeted Therapy; Phenformin; Protein Kinase Inhibitors; Retinoblastoma Protein; Signal Transduction; Thiadiazoles; Xenograft Model Antitumor Assays | 2019 |
[Correction of the function of the sympathoadrenal system in the surgical and combined treatment of patients with cancer of the esophagus and stomach].
Topics: Adrenal Medulla; Adult; Aged; Catecholamines; Combined Modality Therapy; Epinephrine; Esophageal Neoplasms; Esophagus; Female; Gastrectomy; Humans; Immunoglobulin M; Levamisole; Male; Middle Aged; Phenformin; Rosette Formation; Stomach Neoplasms; Sympathetic Nervous System; Vitamin U | 1985 |